Visible Genetics gets access to PE Biosystems technology
This article was originally published in Clinica
Executive Summary
PE Biosystems and Visible Genetics have ended their patent litigation over DNA sequencing equipment and formed a worldwide licensing and collaboration agreement, giving Visible access to certain patents and intellectual property owned or exclusively licensed by PE Biosystems. Visible Genetics will pay PE Biosystems a $25 million licensing fee over the next four years, as well as royalties based on sales.